Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Metronidazole
Galderma (UK) Ltd
D06BX01
Metronidazole
7.5mg/1gram
Cutaneous gel
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13100102; GTIN: 5020465200109
NOTICE RECTO VERSO 147 x 208 PLAN n°09.DRA.2251.R00.2 P24926-2 PMS 432U DIELINES Artwork approved by: Date: Signature: _LAUNCHING DEPARTMENT - Z.I. Galderma_ _74540 ALBY-SUR-CHERAN - FRANCE_ This approval applies to WHOLE TEXT, including barcodes, pre-printed mentions and legal or special labelling constraints. PLEASE CHECK PROOF CAREFULLY TO ENSURE ALL ELEMENTS ARE CORRECT. Product code: P24926-2 Product description: METROGEL BIOGLAN Market: GBR Article: Leaflet Flat size: 147x208 Font size: 8 pt Pharmacode: 887 METROGEL ® 0.75% W/W GEL PACKAGE LEAFLET: INFORMATION FOR THE USER METROGEL 0.75% W/W GEL Metronidazole READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Metrogel is and what it is used for 2. What you need to know before you use Metrogel 3. How to use Metrogel 4. Possible side effects 5. How to store Metrogel 6. Contents of the pack and other information 1. WHAT METROGEL IS AND WHAT IT IS USED FOR • Your doctor has prescribed this gel for your skin condition, rosacea. • It helps to treat the pimples, pustules (spots) and redness found with this condition. • Metrogel contains the active substance metronidazole. Metronidazole belongs to a group of medicines called antiprotozoal and antibacterial agents and has been shown to help to control infection and inflammation in certain skin problems, such as rosacea. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE METROGEL DO NOT USE METROGEL • If you are allergic to metronidazole or any of the other ingredients of this medicine (listed in sectio Read the complete document
OBJECT 1 METROGEL Summary of Product Characteristics Updated 03-Aug-2015 | Galderma (U.K) Ltd 1. Name of the medicinal product Metrogel 0.75% w/w Gel 2. Qualitative and quantitative composition Metronidazole 0.75%. Excipients with known effect: Propylene glycol 5% w/w Hydroxybenzoic acid esters 0.13% w/w For the full list of excipients, see section 6.1 3. Pharmaceutical form Aqueous gel for cutaneous use. 4. Clinical particulars 4.1 Therapeutic indications For the treatment of acute inflammatory exacerbation of rosacea. For the deodorisation of the smell associated with malodorous fungating tumours. 4.2 Posology and method of administration _FOR THE TREATMENT OF ROSACEA: _ Posology For topical administration only. The average period of treatment is three to four months. The recommended duration of treatment should not be exceeded. However, if a clear benefit has been demonstrated, continued therapy for a further three to four months period may be considered by the prescribing physician depending on the severity of the condition. In clinical studies, topical metronidazole therapy for rosacea has been continued for up to 2 years. In the absence of a clear clinical improvement, therapy should be stopped. _Older people_: The dosage recommended in the elderly is the same as that recommended in adults. _Paediatric population_: Not recommended. Safety and efficacy have not been established. Method of administration Metrogel should be applied in a thin layer to the affected areas of the skin twice daily, morning and evening. Areas to be treated should be washed with a mild cleanser before application. Patients may use non-comedogenic and non-astringent cosmetics after application of Metrogel. _FOR THE DEODORISATION OF MALODOROUS FUNGATING TUMOURS:_ Adults and elderly: Clean the wound thoroughly. Apply the gel over the complete area and cover with a non-adherent dressing. Use once or twice daily as necessary. Paediatric population: Not recommended 4.3 Contraindications Hypersensitivity to the active substance or to any of Read the complete document